ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China · Delayed Price · Currency is CNY 10.37
-0.39 (-3.62%)
Nov 13, 2026, 3:00 PM CST
SHA:600479 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,751 | 3,629 | 3,630 | 3,798 | 4,026 | 3,664 |
Revenue Growth | 3.24% | -0.03% | -4.44% | -5.66% | 9.89% | 1.02% |
Gross Profit Gross Profit Growth | 1,807 | 1,765 | 1,679 | 1,748 | 1,731 | 1,626 |
Operating Income Operating Income Growth | 433.97 | 367.18 | 288.57 | 376.42 | 404.85 | 354.6 |
Net Income Net Income Growth | 356.64 | 286.29 | 230.76 | 320.41 | 302.51 | 302.06 |
Earnings Per Share EPS Growth | 0.73 | 0.66 | 0.56 | 0.76 | 0.71 | 0.72 |
EPS Growth | 20.17% | 19.13% | -26.43% | 7.32% | -2.11% | 1.69% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Others Others Growth | 222.13 |
Production of Chinese Medicinal Materials and Decoction Pieces Production of Chinese Medicinal Materials and Decoction Pieces Growth | 148.81 |
Wholesale and Retail of Pharmaceutical Products Wholesale and Retail of Pharmaceutical Products Growth | 1,552 |
Offset of Business Segment Offset of Business Segment Growth | -293.12 |
Drug Production Drug Production Growth | 1,999 |
Total Total Growth | 3,629 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 707.21 | 782.08 | 1,349 | 1,998 | 1,914 | 1,422 |
Total Debt Total Debt Growth | 128.74 | 101.54 | 58.64 | 116.71 | 124.24 | 148.93 |
Net Cash (Debt) Net Cash Growth | 578.46 | 680.55 | 1,291 | 1,881 | 1,789 | 1,273 |
Net Cash Growth | 12.98% | -47.27% | -31.39% | 5.13% | 40.60% | -5.93% |
Net Cash Per Share Net Cash Per Share Growth | 1.19 | 1.58 | 3.12 | 4.45 | 4.18 | 3.04 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 496.77 | 480.24 | 398.77 | 443.12 | 733.47 | 485.57 |
Capital Expenditures CapEx Growth | -141.6 | -124.17 | -47.32 | -43.99 | -34.43 | -71.88 |
Free Cash Flow Free Cash Flow Growth | 355.17 | 356.08 | 351.45 | 399.13 | 699.04 | 413.69 |
Free Cash Flow Growth | -31.56% | 1.32% | -11.95% | -42.90% | 68.97% | -7.06% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 48.18% | 48.65% | 46.25% | 46.02% | 42.98% | 44.38% |
Operating Margin | 11.57% | 10.12% | 7.95% | 9.91% | 10.05% | 9.68% |
Pretax Margin | 12.67% | 11.99% | 9.24% | 12.12% | 11.07% | 11.83% |
Profit Margin | 9.51% | 7.89% | 6.36% | 8.43% | 7.51% | 8.24% |
FCF Margin | 9.47% | 9.81% | 9.68% | 10.51% | 17.36% | 11.29% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.360 | 0.380 | 0.360 | 0.350 | 0.350 | 0.600 |
Dividend Per Share Growth | 0% | 5.56% | 2.86% | 0% | -41.67% | -40.00% |
Dividend Yield | 3.47% | 3.74% | 3.37% | 3.25% | 3.63% | 4.78% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.13 | 17.47 | 19.62 | 14.42 | 13.64 | 17.39 |
Forward PE | - | 13.60 | 13.60 | 13.60 | 13.60 | 13.60 |
P/FCF Ratio | 14.37 | 14.04 | 12.89 | 11.57 | 5.90 | 12.70 |
PS Ratio | 1.36 | 1.38 | 1.25 | 1.22 | 1.02 | 1.43 |